Similarly, a recent study found CRP levels associated with accelerated decline in FEV1 and mortality in patients with mild to moderate COPD, indicating that CRP measurements might enable identification of patients at a high risk of disease progression and mortality [16]. The gene discussed is CRP; the disease is chronic obstructive pulmonary disease.